Breaking News Instant updates and real-time market news.

PFPT

Proofpoint

$87.91

-0.17 (-0.19%)

, CHKP

Check Point

$109.66

-1.14 (-1.03%)

04:55
06/13/17
06/13
04:55
06/13/17
04:55

FBN Securities to hold a tour

Silicon Valley Tech Tour which began on June 8-9 and continues throughout the Silicon Valley on June 12-13.

PFPT

Proofpoint

$87.91

-0.17 (-0.19%)

CHKP

Check Point

$109.66

-1.14 (-1.03%)

MLNX

Mellanox

$45.15

0.05 (0.11%)

GIMO

Gigamon

$40.25

-0.25 (-0.62%)

ANET

Arista Networks

$149.76

0.3 (0.20%)

NOW

ServiceNow

$102.32

-1.42 (-1.37%)

VMW

VMware

$87.36

-0.27 (-0.31%)

CSCO

Cisco

$31.25

-0.12 (-0.38%)

NTAP

NetApp

$38.86

-0.66 (-1.67%)

HPQ

HP Inc.

$17.76

0.0927 (0.52%)

HPE

HP Enterprise

$16.85

-0.075 (-0.44%)

  • 13

    Jun

  • 13

    Jun

  • 13

    Jun

  • 21

    Jun

  • 22

    Jun

  • 12

    Jul

PFPT Proofpoint
$87.91

-0.17 (-0.19%)

06/07/17
06/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kraft Heinz (KHC) initiated with a Buy at Berenberg. 2. NICE Systems (NICE) initiated with a Neutral at Citi. 3. Exxon Mobil (XOM) initiated with a Long-Term Buy at Hilliard Lyons. 4. ASV Holdings (ASV) was initiated with a Buy at Roth Capital and Seaport Global. 5. Check Point (CHKP), Imperva (IMPV), and Proofpoint (PFPT) were initiated with a Positive at Susquehanna. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/06/17
SUSQ
06/06/17
INITIATION
Target $106
SUSQ
Positive
Proofpoint initiated with a Positive at Susquehanna
Susquehanna analyst Anne Meisner initiated Proofpoint with a Positive and a $132 price target saying the recurring nature of the business and strong growth relative to peers deserves a premium multiple.
05/22/17
FBNS
05/22/17
INITIATION
Target $95
FBNS
Outperform
Proofpoint initiated with an Outperform at FBN Securities
FBN Securities analyst Shebly Seyrafi started Proofpoint with an Outperform rating and $95 price target.
05/15/17
JMPS
05/15/17
NO CHANGE
JMPS
CyberArk, Proofpoint should gain from ransomware attack, says JMP Securities
JMP Securities analyst Erik Suppiger says that CyberArk (CYBR) and ProofPoint (PFPT) are particularly well-positioned in the wake of the recent ransomware attack. The analyst says that those companies' solutions "most acutely address ransomware attacks." He recommends buying both stocks but is more upbeat on CyberArk, as he thinks that the stock's 12% decline in the wake of its earnings creates a buying opportunity.
CHKP Check Point
$109.66

-1.14 (-1.03%)

06/06/17
SUSQ
06/06/17
INITIATION
Target $132
SUSQ
Positive
Check Point initiated with a Positive at Susquehanna
Susquehanna analyst Anne Meisner initiated Check Point with a Positive and a $132 price target saying the company has demonstrated considerable stability and financial discipline relative to other cybersecurity companies. Meisner said Check Point's software blade strategy has resulted in double-digit product growth and greater visibility into the financial model and would build positions opportunistically.
04/28/17
04/28/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Western Digital (WDC) upgraded to Overweight on NAND strength at Morgan Stanley with analyst Wamsi Mohan citing better industry trends in both hard disk drives and memory. 2. Check Point (CHKP) upgraded to Equal Weight from Underweight at Barclays with analyst Saket Kalia saying accelerating billings growth in the double digits suggests the company's market position is strengthening. 3. Align Technology (ALGN) upgraded to Outperform from Neutral at Baird with analyst Jeff Johnson citing its many growth levers and many data points suggesting a new level of acceptance for clear aligner therapy. Johnson said the company's revenue acceleration feels like it has staying power, suggesting the stock could trade in historical ranges reserved for preeminent medtech growers. Johnson raised his price target to $155 from $105 on Align Technology shares. 4. Trimble (TRMB) upgraded to Buy from Neutral at Dougherty with analyst Jon Fisher citing the inflection in revenue, earnings beat, and second quarter outlook for growth. 5. United Rentals (URI) upgraded to Buy from Neutral at BofA/Merrill with analyst Ross Gilardi saying pieces are in place for a seasonal rate improvement. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/17
OPCO
05/15/17
NO CHANGE
OPCO
FireEye poised for increased demand after ransomware attack, says Oppenheimer
Oppenheimer analyst Shaul Eyal notes that according to media reports, a global ransomware attack was launched and infected up to 200,000 computers in at least 150 countries on Friday. The analyst believes the "biggest ransomware outbreak ever" could serve as a wake-up call for many organizations and countries delaying a review of their cybersecurity hygiene. In that regard, Eyal believes all cybersecurity vendors under his coverage, namely Check Point (CHKP), CyberArk (CYBR), Fortinet (FTNT), Imperva (IMPV), Mimecast (MIME), Palo Alto Networks (PANW), Splunk (SPLK), Symantec (SYMC), Verint (VRNT), but most notably FireEye (FEYE), are poised for increased demand, particularly in the EMEA region where the attacks were largely focused.
MLNX Mellanox
$45.15

0.05 (0.11%)

04/27/17
PIPR
04/27/17
DOWNGRADE
Target $48
PIPR
Neutral
Mellanox downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski downgraded Mellanox Technologies to Neutral citing the "disappointing" Q1 results. The analyst sees a lack of near-term leverage and limited visibility. He keeps a $48 price target for the shares.
04/27/17
ROTH
04/27/17
DOWNGRADE
Target $53
ROTH
Neutral
Mellanox downgraded to Neutral from Buy at Roth Capital
Roth Capital analyst Brian Alger downgraded Mellanox to Neutral from Buy after the company reported a disappointing Q1. While management believes Infiniband is going to rebound over the next two quarters and should result in a full year of growth revenues, the analyst is not so certain. Alger also lowered his price target on the shares to $53 from $60.
04/27/17
FBCO
04/27/17
DOWNGRADE
FBCO
Neutral
Mellanox downgraded to Neutral from Outperform at Credit Suisse
04/27/17
04/27/17
DOWNGRADE
Target $45

Neutral
Mellanox downgraded to Neutral at Credit Suisse
As previously reported, Credit Suisse analyst John Pitzer downgraded Mellanox to Neutral from Outperform saying that while the company is well levered to his Data Growth Paradigm, execution has been "lackluster." The analyst also lowered his price target on the shares to $45 from $50.
GIMO Gigamon
$40.25

-0.25 (-0.62%)

05/09/17
DADA
05/09/17
DOWNGRADE
Target $40
DADA
Neutral
Gigamon downgraded to Neutral from Buy at DA Davidson
DA Davidson analyst Mark Kelleher downgraded Gigamon to Neutral citing valuation following the recent rally. The analyst believes a sale of the company will be high on the strategic alternatives list for new activist investor Elliott Management. He lists Viavi (VIAV) and NetScout (NTCT) as possible acquirers. Should a deal happen, Kelleher expects a "lack of take-out premium." He raised his price target for Gigamon to $40.
05/09/17
FBCO
05/09/17
NO CHANGE
Target $43
FBCO
Neutral
Gigamon price target raised to $43 from $29 at Credit Suisse
Credit Suisse analyst Kulbinder Garcha raised his price target for Gigamon to $43 from $29, citing increased shareholder activism and potential for sale of the company after Elliott management disclosed a 15.3% stake in Gigamon in its 13D filings. The analyst reiterates a Neutral rating on the shares.
06/05/17
STFL
06/05/17
NO CHANGE
STFL
Gigamon price target raised to $45 from $39 at Stifel
Stifel analyst Patrick Newton raised his price target on Gigamon after activist investor Elliott Associates announced that it had obtained a 15.3% stake in the company. Newton says that "a number of companies" in which Elliott obtained a stake were later sold. He thinks that Elliott will push Gigamon to sell assets, and he says that "test and measurement companies and networking switch companies," along with private equity firms, are potential acquirers of Gigamon. The analyst raised his price target on the stock to $45 from $39 and keeps a Buy rating on the shares.
06/05/17
NEED
06/05/17
NO CHANGE
Target $50
NEED
Buy
Gigamon worth $50-$55 per share to acquirer, says Needham
After Reuters reported that Gigamon (GIMO) has responded to Elliot Management's urging and has undertaken an active review of its options, including a potential sale, Needham analyst Alex Henderson estimated that a fair value for Gigamon is in the $50-$55 range. Henderson - who lists Cisco (CSCO), Juniper (JNPR), F5 (FFIV), HP (HPE), Dell/EMC (EMC), Palo Alto (PANW), and Fortinet (FTNT) among the companies that he thinks could be interested - said he would not be surprised to see Gigamon attract multiple suitors. He raised his price target on Gigamon to $50 from $34 and keeps a Buy rating on the stock.
ANET Arista Networks
$149.76

0.3 (0.20%)

06/02/17
OPCO
06/02/17
NO CHANGE
Target $160
OPCO
Outperform
Arista Networks legal risk is dissipating, says Oppenheimer
Oppenheimer analyst Ittai Kidron says Arista Networks' (ANET) legal risk is dissipating after the Patent and Trial Appeal Board yesterday issued a final decision invalidating all relevant claims of one of the Cisco (CSCO) patents involved in the ongoing Arista/Cisco litigation. This follows a May 25 PTAB decision invalidating a different Cisco patent. Taken together, these decisions are a positive for Arista, Kidron tells investors in a research note. He believes the invalidation of these patents eliminates the infringement and the need to develop workarounds. The analyst keeps an Outperform rating on Arista shares with a $160 price target.
06/01/17
WELS
06/01/17
NO CHANGE
WELS
Arista Networks wins another critical victory against Cisco, says Wells Fargo
Wells Fargo said Arista Networks (ANET) won another critical victory against Cisco (CSCO) in the '945 ITC patent case. The US Patent Trial and Appeal Board invalidated Cisco's '668 patent, which was one of the two patents in the '945 case Arista was found to violated. The firm's analyst said Arista no longer faces a potential injunction that would have prevented it from importing international components and or systems, eliminates the need for workarounds, and prevents Cisco from suing Arista for monetary damages.
05/31/17
RBCM
05/31/17
NO CHANGE
RBCM
Broadcom should report beat and raise results, says RBC Capital
RBC Capital analyst Amit Daryanani expects Broadcom to report beat and raise results, "driven by organic tailwinds in both wireless and wired segments." Among the more specific catalysts are increased content at Apple (AAPL) and Samsung, better margins from deal integration, and the strength of the revenue obtained by its wired business from vendors like Arista Networks (ANET), according to the analyst. He thinks that the company's EPS could exceed $15 this year and exceed $19 by fiscal 2020. He keeps a $260 price target and Top Pick rating on the shares.
06/12/17
NEED
06/12/17
NO CHANGE
Target $175
NEED
Buy
Arista Networks price target raised to $175 on 100G inflection at Needham
Needham analyst Alex Henderson believes Q2 will mark the inflection point in the 100G upgrade cycle, which he thinks will likely result in another acceleration in Arista Networks's Web 2.0 business. Noting that he expects "robust upside" to Arista estimates in 2017 and into 2018, Henderson raised his price target to $175 from $162 and keeps a Buy rating on the shares.
NOW ServiceNow
$102.32

-1.42 (-1.37%)

05/24/17
BERN
05/24/17
INITIATION
BERN
Outperform
ServiceNow initiated with an Outperform at Bernstein
Bernstein analyst Zane Chrane started coverage of ServiceNow with a $120 price target and an Outperform rating. The analyst says that the company's revenue should exceed expectations for many years, making it attractive for longer term investors. He thinks it should benefit from selling newer products to its existing customers and from its large total available market.
05/25/17
SPHN
05/25/17
INITIATION
Target $120
SPHN
Overweight
ServiceNow initiated with an Overweight at Stephens
Stephens analyst Jonathan Ruykhaver initiated ServiceNow with an Overweight and a $120 price target saying checks indicate the company is driving substantial value for customers and expects the Company to capture a meaningful percentage of this value over time.
04/27/17
DADA
04/27/17
NO CHANGE
DADA
ServiceNow reported 'blowout' Q1 results, says DA Davidson
DA Davidson analyst Jack Andrews believes that ServiceNow reported "blowout" Q1 results, and the analyst raised his price target on the stock to $118 from $102. He keeps a Buy rating on the shares.
05/25/17
MSCO
05/25/17
NO CHANGE
Target $124
MSCO
Overweight
ServiceNow price target raised to $124 from $114 at Morgan Stanley
Morgan Stanley analyst Keith Weiss raised ServiceNow's price target to $124 from $114 given the strong business model, expanding market opportunity, and said shares remain undervalued. Weiss said Service remains the most attractive asset in software and reiterated his Overweight rating.
VMW VMware
$87.36

-0.27 (-0.31%)

05/31/17
05/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Donaldson (DCI) upgraded to Buy from Hold at Jefferies with analyst Laurence Alexander saying he sees "increasing evidence" the company's end-markets are exiting the multi-year trough and believes operating leverage should translate into above-average compound growth over the next few years. He recommends building positions in the stock during the second half of 2017. 2. VMware (VMW) upgraded to Outperform from Neutral at Baird with analyst Jason Noland citing the company's strategic shift to partner with firms rather than compete with the public cloud. 3. Akari Therapeutics (AKTX) upgraded to Neutral from Sell at Chardan. 4. Vale (VALE) upgraded to Buy from Hold at HSBC with analyst Jonathan Brandt saying the recent decline in iron ore prices has mitigated risk, and the focus should now shift to the company's "strong" free cash flow generation and 6% dividend yield. 5. Potbelly (PBPB) upgraded to Buy from Hold at Maxim with analyst Stephen Anderson citing news that Chief Executive Officer Aylwin Lewis is resigning, as he believes new management could reinvigorate performance. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/02/17
RAJA
06/02/17
NO CHANGE
Target $106
RAJA
Outperform
VMware price target raised to $106 from $98 at Raymond James
Raymond James analyst Michael Turits raised VMware's price target to $106 from $98 and reiterated his Outperform rating following the "strong" Q1 report and raised FY18 guidance.
06/02/17
JEFF
06/02/17
NO CHANGE
Target $116
JEFF
Buy
VMware price target raised to $116 from $105 at Jefferies
Jefferies analyst John DiFucci raised his price target for VMware to $116 saying the company reported "strong" Q1 results when adjusting for the vCloud Air sale and the shift in fiscal year. The analyst believes VMware is seeing strength across all its businesses. He keeps a Buy rating on the shares.
05/31/17
BARD
05/31/17
UPGRADE
Target $115
BARD
Outperform
VMware upgraded to Outperform at Baird
As reported previously, Baird analyst Jason Noland upgraded VMware (VMW) to Outperform from Neutral citing the company's strategic shift to partner with firms rather than compete with the public cloud. The analyst believes the company's deal with Amazon Web Services (AMZN) is a big deal and believes its parent Dell will be able to help with harder-to-reach geographies with cost effectiveness. Noland raised his price target to $115 from $90 on VMware shares.
CSCO Cisco
$31.25

-0.12 (-0.38%)

06/05/17
CHLM
06/05/17
NO CHANGE
Target $12.5
CHLM
Buy
Extreme Networks set to enter top 3 in enterprise networking, says Craig-Hallum
Craig-Hallum analyst Christian Schwab noted that Extreme Networks (EXTR) is poised to become the third largest enterprise networking vendor - behind Cisco (CSCO) and HP Enterprise (HPE) - post the closing of its deals with Avaya and Brocade (BRCD). Management has introduced a FY18 target for revenue of over $1B and, combined with its just revealed margin targets, Extreme should be earning 90c-95c per share annually, estimated Schwab, who reiterates his Buy rating and $12.50 price target on the stock following the company's analyst day.
NTAP NetApp
$38.86

-0.66 (-1.67%)

05/25/17
FBCO
05/25/17
UPGRADE
FBCO
Neutral
NetApp upgraded to Neutral from Underperform at Credit Suisse
Credit Suisse Kulbinder Garcha upgraded NetApp to Neutral and raised its price target to $37 from $35 citing limited downside following solid Q4 results, but cautious guidance. The analyst said operating margins are expected to improve through the year and revenue growth is coming through.
05/26/17
UBSW
05/26/17
UPGRADE
Target $40
UBSW
Neutral
NetApp upgraded to Neutral from Sell at UBS
UBS analyst Steven Milunovich upgraded NetApp to Neutral citing new management's return to revenue growth and improved margins. The analyst sees few negative catalysts over the next year and has a $40 price target for the shares.
05/25/17
PIPR
05/25/17
NO CHANGE
Target $50
PIPR
Overweight
NetApp bear thesis falling apart, says Piper Jaffray
Piper Jaffray analyst Andrew Nowinski believe the bear thesis on NetApp is falling apart after the company's "strong" Q4 results. Management continues to execute on their plan to deliver low double-digit earnings growth, Nowinski tells investors in a post-earnings research note. He attributes the after-hours selloff to the lower than expected Q1 earnings outlook and recommends adding to positions at these levels. Nowinski has an Overweight rating on the stock with a $50 price target.
05/25/17
FBNS
05/25/17
UPGRADE
FBNS
Outperform
NetApp upgraded to Outperform from Sector Perform at FBN Securities
HPQ HP Inc.
$17.76

0.0927 (0.52%)

05/25/17
BERN
05/25/17
NO CHANGE
BERN
HP Inc. 2017 guidance conservative, says Bernstein
Bernstein analyst A.M. Sacconaghi, Jr says that HP posted "good" Q1 results. The analyst thinks that the company's fiscal 2017 free cash flow and EPS guidance are conservative. Sacconaghi says that HP's valuation "is no longer compelling" and thinks that the company will have difficulty growing its revenue over the longer term. However, the analyst keeps a $21 price target and Outperform rating on the stock.
05/25/17
UBSW
05/25/17
NO CHANGE
Target $22
UBSW
HP Inc. posted a "breakthrough quarter" , says UBS
UBS analyst Steven Milunovich said HP Inc. (HPQ) posted a "breakthrough quarter" and is now growing faster than its spinoff, HP Enterprise (HPE). He said both printer and printer supplies revenues growth bottomed this quarter and with its stabilization, free cash flow will probably be at the top end of his estimate range of $2.6B. He is also kept optimistic by the eventual growth in A3 copying and 3D printing. Milunovich reiterated his Buy rating and raised his price target to $22 from $20 on HP, Inc. shares.
05/25/17
SBSH
05/25/17
NO CHANGE
Target $45
SBSH
Buy
HP earnings report good for Micron, says Citi
Citi analyst Christopher Danely says HP Inc.'s (HPQ) earnings report last night, which showed good PC demand and tight DRAM supply, is positive for Micron (MU). He notes that his checks also indicate good PC demand and increasing DRAM pricing. The analyst recommends staying long Micron with a Buy rating and $45 price target.
05/25/17
05/25/17
NO CHANGE
Target $20

Buy
Citi still likes HP Inc. shares for three reasons
Following the company's Q2 earnings report, Citi analyst Jim Suva says he still likes the shares for three reasons. Printing revenues are now increasing year-over-year, PC end markets are seeing the best demand in five years, and HP is putting in average selling price increases to protect margins, Suva tells investors in a post-earnings research note. He points out that Q2 was the first time since 2010 that the company saw both PC and printing sales growth year-over-year. The analyst reiterates a Buy rating on the shares with a $20 price target.
HPE HP Enterprise
$16.85

-0.075 (-0.44%)

06/01/17
FBCO
06/01/17
NO CHANGE
Target $21
FBCO
Outperform
HP Enterprise earnings guidance remains conservative, says Credit Suisse
Credit Suisse analyst Kulbinder Garcha believes HP Enterprise's EPS guidance for its "RemainCo" following the Software spin-merger planned for September remains conservative at $1.13-$1.23 and his own estimate of RemainCo EPS power of $1.25 will also prove conservative. While its Q2 margins were weaker than expected, Garcha views the margin pressures as transitory, he added. The analyst keeps his Outperform rating and $21 price target on HP Enterprise shares.
06/01/17
UBSW
06/01/17
NO CHANGE
Target $21
UBSW
Buy
UBS believes worst may be over for HP Enterprise
UBS analyst Steven Milunovich noted HP Enterprise reported Q2 results in-line with expectations but said products lost money, the company was unable to raise prices due to competition, and its breakup with Microsoft (MSFT) in the cloud business had a more negative impact than thought. Milunovich feels, however, the worst may be over for the company as headwinds begin to moderate and its current valuation remains low. Milunovich maintained his Buy rating and $21 price target on HP Enterprise shares.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.